Magnetic Resonance Imaging Contrast Media Market

Contrast agents, also called contrast media, are substances used to enhance the radiodensity of a targeted tissue by altering the way that electromagnetic radiation or ultrasound waves pass through the body. These substances can be administered to the patient orally, rectally, or intravenously.

Magnetic Resonance Imaging Contrast Media Market contains market size and forecasts of Magnetic Resonance Imaging Contrast Media in global, including the following market information:

Global Magnetic Resonance Imaging Contrast Media Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Magnetic Resonance Imaging Contrast Media Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Magnetic Resonance Imaging Contrast Media companies in 2021 (%)

The global Magnetic Resonance Imaging Contrast Media market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Iodine Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Magnetic Resonance Imaging Contrast Media include Jiangsu Hengrui Medicine Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Ge Healthcare Shanghai Co., Ltd., BAYER, Shanghai Bracco Sine Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Beijing Beilu Pharmaceutical Co.,Ltd., Starry Pharmaceutical and Guerbet. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Magnetic Resonance Imaging Contrast Media manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Magnetic Resonance Imaging Contrast Media Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging Contrast Media Market Segment Percentages, by Type, 2021 (%)

Iodine Based

Barium Sulfate Compounds

Global Magnetic Resonance Imaging Contrast Media Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging Contrast Media Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Other

Global Magnetic Resonance Imaging Contrast Media Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnetic Resonance Imaging Contrast Media Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Magnetic Resonance Imaging Contrast Media revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Magnetic Resonance Imaging Contrast Media revenues share in global market, 2021 (%)

Key companies Magnetic Resonance Imaging Contrast Media sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Magnetic Resonance Imaging Contrast Media sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Jiangsu Hengrui Medicine Co.,Ltd.

Yangtze River Pharmaceutical (Group) Co., Ltd.

Ge Healthcare Shanghai Co., Ltd.

BAYER

Shanghai Bracco Sine Pharmaceutical Co., Ltd.

Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.

Beijing Beilu Pharmaceutical Co.,Ltd.

Starry Pharmaceutical

Guerbet